AU3830899A - Composition based on pentoxifylline and anticytokin - Google Patents

Composition based on pentoxifylline and anticytokin

Info

Publication number: AU3830899A
Authority: AU; Australia
Prior art keywords: anticytokin; pentoxifylline; composition based; composition
Prior art date: 1998-05-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU38308/99A

Inventor

Sylvie Delanian

Jean-Louis Lefaix

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Assistance Publique Hopitaux de Paris APHP

Commissariat a lEnergie Atomique et aux Energies Alternatives CEA

Original Assignee

Commissariat a lEnergie Atomique CEA

Assistance Publique Hopitaux de Paris APHP

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-29

Filing date

1999-05-21

Publication date

1999-12-20

1999-05-21 Application filed by Commissariat a lEnergie Atomique CEA, Assistance Publique Hopitaux de Paris APHP filed Critical Commissariat a lEnergie Atomique CEA

1999-12-20 Publication of AU3830899A publication Critical patent/AU3830899A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Cardiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU38308/99A 1998-05-29 1999-05-21 Composition based on pentoxifylline and anticytokin Abandoned AU3830899A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9806807A FR2779063A1 (en)	1998-05-29	1998-05-29	PENTOXIFYLLIN COMPOSITIONS AND THEIR THERAPEUTIC USE
FR9806807		1998-05-29
PCT/FR1999/001208 WO1999062543A1 (en)	1998-05-29	1999-05-21	Composition based on pentoxifylline and anticytokin

Publications (1)

Publication Number	Publication Date
AU3830899A true AU3830899A (en)	1999-12-20

Family

ID=9526861

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU38308/99A Abandoned AU3830899A (en)	1998-05-29	1999-05-21	Composition based on pentoxifylline and anticytokin

Country Status (9)

Country	Link
EP (1)	EP1079852B1 (en)
JP (1)	JP2002528384A (en)
AU (1)	AU3830899A (en)
CA (1)	CA2333776A1 (en)
DE (1)	DE69900336T2 (en)
ES (1)	ES2165734T3 (en)
FR (1)	FR2779063A1 (en)
IL (1)	IL139961A0 (en)
WO (1)	WO1999062543A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6294350B1 (en) *	1997-06-05	2001-09-25	Dalhousie University	Methods for treating fibroproliferative diseases
FR2862879B1 (en) *	2003-11-27	2006-04-28	Alchimer S A	ORGANIC BIOACTIVE COATINGS APPLICABLE TO VASCULAR STENTS
EP2219650B1 (en)	2007-10-26	2014-05-07	Pacific Therapeutics Ltd.	Compositions and methods for treating fibroproliferative disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332041C2 (en) *	1993-09-21	1997-12-11	Rentschler Arzneimittel	Use of pentoxifylline in certain lung diseases

1998
- 1998-05-29 FR FR9806807A patent/FR2779063A1/en active Pending
1999
- 1999-05-21 CA CA002333776A patent/CA2333776A1/en not_active Abandoned
- 1999-05-21 DE DE69900336T patent/DE69900336T2/en not_active Expired - Lifetime
- 1999-05-21 ES ES99920904T patent/ES2165734T3/en not_active Expired - Lifetime
- 1999-05-21 WO PCT/FR1999/001208 patent/WO1999062543A1/en not_active Ceased
- 1999-05-21 IL IL13996199A patent/IL139961A0/en unknown
- 1999-05-21 JP JP2000551798A patent/JP2002528384A/en active Pending
- 1999-05-21 EP EP99920904A patent/EP1079852B1/en not_active Expired - Lifetime
- 1999-05-21 AU AU38308/99A patent/AU3830899A/en not_active Abandoned

Also Published As

Publication number	Publication date
FR2779063A1 (en)	1999-12-03
EP1079852A1 (en)	2001-03-07
DE69900336T2 (en)	2002-06-27
DE69900336D1 (en)	2001-11-08
WO1999062543A1 (en)	1999-12-09
JP2002528384A (en)	2002-09-03
ES2165734T3 (en)	2002-03-16
IL139961A0 (en)	2002-02-10
EP1079852B1 (en)	2001-10-04
CA2333776A1 (en)	1999-12-09

Publication	Publication Date	Title
AU4208799A (en)	1999-12-13	Interleukins-21 and 22
AU9790198A (en)	1999-04-27	Compounds and methods
AU3008297A (en)	1997-12-05	Dihydropyrimidines and uses thereof
AU5245498A (en)	1998-05-29	Improved surface for sports and other uses
AU2440997A (en)	1997-10-29	Calixpyrroles, calixpyridinopyrroles and calixpyridines
AU9781998A (en)	1999-04-12	Huchordin and uses thereof
AU4198299A (en)	1999-12-06	Compounds and uses thereof
AU2349399A (en)	1999-08-16	R-lansoprazole compositions and methods
AU2972597A (en)	1998-01-05	Compositions and uses thereof
AU5335798A (en)	1999-05-10	Stomatic composition
AU2592299A (en)	1999-09-15	Sailboats and methods
AUPP433398A0 (en)	1998-07-16	Compounds and processes
AU9301998A (en)	1999-03-22	Composition and methods using galectin-1
AU8121998A (en)	1999-01-25	Composition
AU8695298A (en)	1999-03-01	Compounds and uses thereof
AU2333099A (en)	1999-10-18	Aryloxyanilides and related compounds
AU3200197A (en)	1998-01-07	New composition and methods
AU1098499A (en)	1999-05-10	Emulsifier-lipid composition
AU4198899A (en)	2000-12-12	Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AUPO982097A0 (en)	1997-11-06	Methods and compositions for use therein
AU3830899A (en)	1999-12-20	Composition based on pentoxifylline and anticytokin
AU2980799A (en)	1999-09-20	Lectomedin materials and methods
AU1046799A (en)	1999-05-31	Compound, composition and use
AU8693198A (en)	1999-03-01	Compounds and uses thereof
AU3900499A (en)	1999-12-06	(+)-hydroxyrisperidone compositions and methods

Legal Events

Date	Code	Title	Description
2000-05-04	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
2000-07-27	TH	Corrigenda	Free format text: IN VOL 14, NO 13, PAGE(S) 2269-2273 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 38308/99 AND 16764/00
2001-02-22	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase